Granules India appoints Vinodkumar Parur as CHRO

Written By :  Ruchika Sharma
Published On 2025-11-13 10:15 GMT   |   Update On 2025-11-13 10:15 GMT
Advertisement

Telangana: Granules India has announced the appointment of Vinodkumar Parur as the Chief Human Resources Officer (CHRO) of the Company, effective November 17, 2025, and has been designated as one of the Senior Management Personnel (SMP) of the Company.

His appointment follows the resignation of Atul Dhavle from the position of CHRO on November 16, 2025. However, he will serve his notice period for the transition.
Advertisement
Vinodkumar Parur has over 24 years of experience in human resources leadership across multiple sectors, including manufacturing, engineering, pharmaceuticals and infrastructure. Parur has been involved in HR function setup for IPO preparation, mergers and acquisitions, implementation of HRMS systems, leadership development and employee engagement programs.

His previous senior roles include Chief Human Resources Officer at RR Kabel Limited & Nilkamal Limited and senior HR leadership roles at A.T.E. Group & Schindler India.

He holds a master’s degree in management studies (Human Resources) from PIMSR, Mumbai University, and a bachelor’s degree in commerce and economics from NMIMS, Mumbai University. He is certified in several HR assessment and training programs and is a member of advisory and academic boards.

Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad with best-in-class facilities. Amongst the few pharmaceutical companies in the world to be present across the manufacturing of the entire pharmaceutical value chain — from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFls), and Finished Dosages (FDs), Granules products are distributed to over 300+ customers in regulated and semi-regulated markets with a global presence extending to over 80+ countries with offices across India, US and UK. The Company has 10 manufacturing facilities out of which 8 are located in India and 2 are in the USA and has regulatory approvals from the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News